Jade Biosciences Announces Appointment of Mark Eisner, M.D., M.P.H., to Board of Directors
Jade Biosciences appointed Dr. Mark Eisner, M.D., M.P.H., to its Board of Directors, effective immediately. Dr. Eisner brings over 25 years of experience, having served as Executive Vice President and Chief Medical Officer at Vir Biotechnology and holding leadership roles at Genentech/Roche and FibroGen.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.